Skip to content

Therapeutic effect of percutaneous electroacupuncture combined with adaptive biofeedback in the treatment of outlet obstructive constipation

Therapeutic effect of percutaneous electroacupuncture combined with adaptive biofeedback in the treatment of outlet obstructive constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037449
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

outlet obstructed constipation

Interventions

Sponsors

Anhui Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. There was evidence of outlet obstruction and met Rome IV diagnostic criteria for functional constipation 2. Aged 18 to 65 years old male and female; 3. Colonoscopy was performed in a Grade-A hospital one year before the enrollment to exclude intestinal cancer, ulcer, inflammation or other organic intestinal diseases; 4. B-ultrasound examination was performed in a Grade-A hospital one year before admission to exclude hepatobiliary and pancreatic diseases; 5. The patients with normal ECG examination in our center one month before admission (QT interval was within normal range).

Exclusion criteria

Exclusion criteria: 1. Have a history of abdominal surgery; 2. Organic diseases of digestive system (including polyps, inflammatory bowel disease, tumor, celiac disease, lactose intolerance, etc.); 3. Any antispasmodic and analgesic drugs, gastrointestinal motility drugs, acid inhibitors, microecological agents, antibiotics, antidepressants, etc. were used within 2 weeks before enrollment; 4. B ultrasound examination of liver, gallbladder and pancreas diseases; 5. People with hypertension and unstable blood pressure control; 6. Patients with diabetes mellitus, thyroid disease, systemic sclerosis, systemic lupus erythematosus, etc; 7. Patients with severe psychological disorders; 8. pregnant women, lactating women or planned pregnancies; 9. There are allergic patients taking polyethylene glycol 4000 powder; 10. Observation contents: (1) Basic information collection; (2) Constipation symptom severity score pac-sym; (3) Constipation quality of life score pac-qol; (4) Anal sphincter pressure during defecation; (5) Changes of serum psychosomatic neurotransmitters (conditional units).

Design outcomes

Primary

MeasureTime frame
PAC-SYM;PAC-QOL;anal defedating pressure;Changes of Serum Psychological Related Neurotransmitters;

Countries

China

Contacts

Public ContactYu Yue

Anhui Provincial Hospital

yuyuemd@163.com+86 18963788890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026